Bayer Aktiengesellschaft (BAYRY) News Today $5.64 -0.07 (-1.23%) As of 01/31/2025 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartDividendEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Short Interest Up 412.2% in JanuaryBayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) was the target of a large growth in short interest in January. As of January 15th, there was short interest totalling 447,700 shares, a growth of 412.2% from the December 31st total of 87,400 shares. Based on an average trading volume of 2,936,800 shares, the days-to-cover ratio is currently 0.2 days.January 30 at 6:36 PM | marketbeat.comBerenberg Bank Reaffirms Their Hold Rating on Bayer (0P6S)January 29 at 12:39 AM | markets.businessinsider.comJ.P. Morgan Sticks to Their Hold Rating for Bayer (0P6S)January 21, 2025 | markets.businessinsider.comBayer AG Enterprise Digital Transformation Strategy Report 2024: Accelerators, Incubators, and Innovation ProgramsJanuary 20, 2025 | globenewswire.comLeaps by Bayer Announces One of the Largest Global Surveys of Society's Attitudes Toward Breakthrough TechnologiesJanuary 20, 2025 | businesswire.comBayer Aktiengesellschaft (OTCMKTS:BAYRY) Stock Price Passes Above 50 Day Moving Average - Here's WhyBayer Aktiengesellschaft (OTCMKTS:BAYRY) Share Price Crosses Above 50 Day Moving Average - Here's WhyJanuary 18, 2025 | marketbeat.comBayer Aktiengesellschaft (OTCMKTS:BAYRY) Share Price Crosses Above 50-Day Moving Average - Here's What HappenedBayer Aktiengesellschaft (OTCMKTS:BAYRY) Stock Price Crosses Above 50 Day Moving Average - Here's WhyJanuary 18, 2025 | marketbeat.comNew U.S. Survey Conducted On Behalf Of One A Day® by Bayer Highlights Four in Five GenZ Women Feel Societal Pressures Impact Their New Year's ResolutionsJanuary 17, 2025 | businesswire.comYourUpdateTV Speaks with Kelly Bristow from Bayer About Simple Tips for a Healthier 2025January 17, 2025 | globenewswire.comBayer AG Prepares to Release 2024 Financial ReportsJanuary 15, 2025 | tipranks.comBayer sees new drugs boosting return to growth in 2027, WSJ reportsJanuary 15, 2025 | markets.businessinsider.comJury says Bayer must pay $100M in trial over PCBs in Washington schoolJanuary 15, 2025 | msn.comBayer must pay $100 million in latest trial over PCBs in Washington school, jury findsJanuary 14, 2025 | reuters.comBayer's Pharma Growth Strategy Progressing Well as Pipeline AdvancesJanuary 14, 2025 | businesswire.comCopper Ammonium Carbonate Market Outlook 2025-2030, with Competitive Analysis of Bayer, Hindalco, Hindustan Copper, Bhagyanagar India, ABC Gas, Gujarat Mineral Development and Baroda ExtrusionJanuary 14, 2025 | globenewswire.comBayer pharma chief sees no big acquisitions in near futureJanuary 14, 2025 | reuters.comBayer's investigational MRI contrast agent gadoquatrane meets primary and main secondary endpoints in pivotal Phase III studiesJanuary 10, 2025 | businesswire.comBayer Submits Supplemental New Drug Application to U.S. FDA Seeking New Indication for KERENDIA® (finerenone) in Patients with Heart Failure with Left Ventricular Ejection Fraction of ≥40%January 10, 2025 | businesswire.comBayer hot flashes therapy for breast cancer patients hits main goal in late-stage trialJanuary 10, 2025 | msn.comBayer menopause drug reduces hot flashes in breast cancer groupJanuary 9, 2025 | detroitnews.comBayer's Elinzanetant Meets Primary, Secondary Endpoints In Phase III OASIS 4 Breast Cancer StudyJanuary 9, 2025 | markets.businessinsider.comCutting Middle Management: Bayer's Costly Experiment One Year LaterJanuary 8, 2025 | forbes.comBernstein Sticks to Their Hold Rating for Bayer (0P6S)January 7, 2025 | markets.businessinsider.comOrion's collaboration partner Bayer submits application in China for third indication of darolutamideJanuary 7, 2025 | globenewswire.comBayer wins last pending Roundup case in AustraliaJanuary 3, 2025 | seekingalpha.comBayer: Federal Court Brings an End to Roundup™ Litigation in AustraliaJanuary 3, 2025 | businesswire.comBayer: Sell And Be Done With ItJanuary 3, 2025 | seekingalpha.comTwo companies - Bayer and Corteva - own thousands of patents related to seedsDecember 30, 2024 | usatoday.comShort Interest in Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Decreases By 33.8%Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) saw a significant decline in short interest in the month of December. As of December 15th, there was short interest totalling 91,700 shares, a decline of 33.8% from the November 30th total of 138,600 shares. Based on an average daily trading volume, of 2,921,900 shares, the days-to-cover ratio is presently 0.0 days.December 28, 2024 | marketbeat.comBayer Aktiengesellschaft (OTCMKTS:BAYRY) Reaches New 12-Month Low - Here's What HappenedBayer Aktiengesellschaft (OTCMKTS:BAYRY) Hits New 12-Month Low - What's Next?December 24, 2024 | marketbeat.comBayer Aktiengesellschaft (OTCMKTS:BAYRY) Reaches New 52-Week Low - Time to Sell?Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Sets New 52-Week Low - Time to Sell?December 18, 2024 | marketbeat.comBayer Gets EU Backing for Heart Drug, Easing Patent ConcernsDecember 13, 2024 | bloomberg.comBayer Aktiengesellschaft (OTCMKTS:BAYRY) Short Interest UpdateBayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) was the recipient of a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 138,600 shares, an increase of 34.8% from the November 15th total of 102,800 shares. Based on an average trading volume of 4,269,100 shares, the short-interest ratio is currently 0.0 days.December 13, 2024 | marketbeat.comBayer's Stock Hits 2-Decade Low: Why It Is A Buy AgainDecember 6, 2024 | seekingalpha.comBayer Showcases Growing Radiology Portfolio at RSNA 2024December 1, 2024 | businesswire.comBayer Patent Cliff Is Actually More of a Dent, Pharma Head SaysNovember 29, 2024 | bloomberg.comWatermelon Seeds Market Analysis Report 2025-2030, Featuring Bayer CropScience, Vilmorin & Cie, Syngenta, Origene Seeds, GoldSupplier, Tokita Seed Co., Emerald Seed Company & HazeraNovember 29, 2024 | globenewswire.comBayer Aktiengesellschaft (OTCMKTS:BAYRY) Sets New 1-Year Low - Here's WhyBayer Aktiengesellschaft (OTCMKTS:BAYRY) Hits New 52-Week Low - What's Next?November 27, 2024 | marketbeat.comBayer (BAYRY) Receives a Hold from Berenberg BankNovember 20, 2024 | markets.businessinsider.comBayer acquires rights to Cytokinetics' heart drug in JapanNovember 19, 2024 | reuters.comBayer’s Worst Week in a Year Puts Scale of CEO Task Into ContextNovember 16, 2024 | bloomberg.comORIC: Working with Two Pharma Giants, Analysts See +100% UpsideORIC Pharmaceuticals is a stock analyst price targets currently signal double-bagger potential in. See what the excitement around this firm is all about.November 16, 2024 | marketbeat.comBayer shareholders call on CEO to stem the tide of bad newsNovember 15, 2024 | reuters.comBayer to Present New Prespecified Subgroup Analyses from Investigational Phase III FINEARTS-HF Trial in Patients with Heart Failure with LVEF ≥40% at AHA 2024November 14, 2024 | businesswire.comBayer AG (BAYRY) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ChallengesNovember 13, 2024 | gurufocus.com‘Xabi Alonso will find a solution’ – Aleix Garcia on Bayer Leverkusen’s poor startNovember 13, 2024 | sports.yahoo.comBayer extends contract of CFO Wolfgang NicklNovember 12, 2024 | markets.businessinsider.comBayer Stock Slips On Q3 Loss, Cautious Outlook November 12, 2024 | rttnews.comBayer Lowers Earnings Guidance on Weak Crop Unit PerformanceNovember 12, 2024 | bloomberg.comBayer drops after guidance cutNovember 12, 2024 | msn.com Get Bayer Aktiengesellschaft News Delivered to You Automatically Sign up to receive the latest news and ratings for BAYRY and its competitors with MarketBeat's FREE daily newsletter. Email Address BAYRY Media Mentions By Week BAYRY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BAYRY News Sentiment▼0.230.69▲Average Medical News Sentiment BAYRY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BAYRY Articles This Week▼310▲BAYRY Articles Average Week Get Bayer Aktiengesellschaft News Delivered to You Automatically Sign up to receive the latest news and ratings for BAYRY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CSL News Today Zoetis News Today Regeneron Pharmaceuticals News Today GSK News Today Takeda Pharmaceutical News Today UCB News Today Alnylam Pharmaceuticals News Today Teva Pharmaceutical Industries News Today Merck KGaA News Today Merck KGaA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BAYRY) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump vs. TexasEver since Donald Trump won the election, U.S. states have been rushing to pass new currency rules. These r...Stansberry Research | SponsoredTurning Panic Into OpportunityAI stocks were hammered on Jan. 27. That includes Nvidia, the undisputed leader in the artificial intellige...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWill Elon trigger another AI flash crash?AI continues to dominate financial headlines in 2025...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bayer Aktiengesellschaft Please log in to your account or sign up in order to add this asset to your watchlist. Share Bayer Aktiengesellschaft With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
